BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1252 related articles for article (PubMed ID: 17944556)

  • 1. Human resources for treating HIV/AIDS: needs, capacities, and gaps.
    Bärnighausen T; Bloom DE; Humair S
    AIDS Patient Care STDS; 2007 Nov; 21(11):799-812. PubMed ID: 17944556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020.
    Dutta A; Barker C; Kallarakal A
    PLoS Med; 2015 Nov; 12(11):e1001907; discussion e1001907. PubMed ID: 26599990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Conditional scholarships" for HIV/AIDS health workers: educating and retaining the workforce to provide antiretroviral treatment in sub-Saharan Africa.
    Bärnighausen T; Bloom DE
    Soc Sci Med; 2009 Feb; 68(3):544-51. PubMed ID: 19081662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of antiretroviral therapy coverage: methodology and trends.
    Mahy M; Tassie JM; Ghys PD; Stover J; Beusenberg M; Akwara P; Souteyrand Y
    Curr Opin HIV AIDS; 2010 Jan; 5(1):97-102. PubMed ID: 20046154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Resources for Treating HIV/AIDS: Are the Preventive Effects of Antiretroviral Treatment a Game Changer?
    Bärnighausen T; Bloom DE; Humair S
    PLoS One; 2016; 11(10):e0163960. PubMed ID: 27716813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Socioeconomic aspects of human immunodeficiency virus (HIV) infection in developing countries].
    Gentilini M; Chieze F
    Bull Acad Natl Med; 1990 Nov; 174(8):1209-19; discussion 1219-21. PubMed ID: 2094555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Provision of antiretroviral therapy in South Africa: unique challenges and remaining obstacles.
    Ojikutu B; Jack C; Ramjee G
    J Infect Dis; 2007 Dec; 196 Suppl 3():S523-7. PubMed ID: 18181705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies to optimize HIV treatment outcomes in resource-limited settings.
    Nakanjako D; Colebunders R; Coutinho AG; Kamya MR
    AIDS Rev; 2009; 11(4):179-89. PubMed ID: 19940945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community-supported models of care for people on HIV treatment in sub-Saharan Africa.
    Bemelmans M; Baert S; Goemaere E; Wilkinson L; Vandendyck M; van Cutsem G; Silva C; Perry S; Szumilin E; Gerstenhaber R; Kalenga L; Biot M; Ford N
    Trop Med Int Health; 2014 Aug; 19(8):968-77. PubMed ID: 24889337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scale-up of HIV Viral Load Monitoring--Seven Sub-Saharan African Countries.
    Lecher S; Ellenberger D; Kim AA; Fonjungo PN; Agolory S; Borget MY; Broyles L; Carmona S; Chipungu G; De Cock KM; Deyde V; Downer M; Gupta S; Kaplan JE; Kiyaga C; Knight N; MacLeod W; Makumbi B; Muttai H; Mwangi C; Mwangi JW; Mwasekaga M; Ng'Ang'A LW; Pillay Y; Sarr A; Sawadogo S; Singer D; Stevens W; Toure CA; Nkengasong J
    MMWR Morb Mortal Wkly Rep; 2015 Nov; 64(46):1287-90. PubMed ID: 26605986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral therapy for HIV prevention: many concerns and challenges, but are there ways forward in sub-Saharan Africa?
    Zachariah R; Harries AD; Philips M; Arnould L; Sabapathy K; O'Brien DP; Ferreyra C; Balkan S
    Trans R Soc Trop Med Hyg; 2010 Jun; 104(6):387-91. PubMed ID: 20116814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term financing needs for HIV control in sub-Saharan Africa in 2015-2050: a modelling study.
    Atun R; Chang AY; Ogbuoji O; Silva S; Resch S; Hontelez J; Bärnighausen T
    BMJ Open; 2016 Mar; 6(3):e009656. PubMed ID: 26948960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Community organizations and fighting STDs, HIV and AIDS in Montreal: lessons for sub-Saharan Africa].
    Agonnoude MT; Mesenge C
    Sante; 2010; 20(2):116-24. PubMed ID: 20685643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to achieve the global 90-90-90 target by 2020 in sub-Saharan Africa? A mathematical modelling study.
    Estill J; Marsh K; Autenrieth C; Ford N
    Trop Med Int Health; 2018 Nov; 23(11):1223-1230. PubMed ID: 30156355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extent to which low-level use of antiretroviral treatment could curb the AIDS epidemic in sub-Saharan Africa.
    Wood E; Braitstein P; Montaner JS; Schechter MT; Tyndall MW; O'Shaughnessy MV; Hogg RS
    Lancet; 2000 Jun; 355(9221):2095-100. PubMed ID: 10902622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress and prospects for the control of HIV and tuberculosis in South Africa: a dynamical modelling study.
    Williams BG; Gupta S; Wollmers M; Granich R
    Lancet Public Health; 2017 May; 2(5):e223-e230. PubMed ID: 29253488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of adult antiretroviral treatment coverage in South Africa.
    Adam MA; Johnson LF
    S Afr Med J; 2009 Sep; 99(9):661-7. PubMed ID: 20073293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV testing and treatment coverage achieved after 4 years across 14 urban and peri-urban communities in Zambia and South Africa: An analysis of findings from the HPTN 071 (PopART) trial.
    Floyd S; Shanaube K; Yang B; Schaap A; Griffith S; Phiri M; Macleod D; Sloot R; Sabapathy K; Bond V; Bock P; Ayles H; Fidler S; Hayes R;
    PLoS Med; 2020 Apr; 17(4):e1003067. PubMed ID: 32240156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epidemiology of HIV].
    Ledergerber B; Battegay M
    Ther Umsch; 2014 Aug; 71(8):437-41. PubMed ID: 25093307
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 63.